Monte Rosa Therapeutics, Inc. — Investor Relations & Filings
Monte Rosa Therapeutics is a clinical-stage biotechnology company that develops small molecule precision medicines known as molecular glue degraders (MGDs). The company's proprietary drug discovery platform is engineered to rationally design MGDs that leverage the body's natural protein disposal system to selectively eliminate disease-causing proteins. This approach targets proteins that have been historically considered "undruggable" or are inadequately addressed by existing therapies. By integrating expertise in chemistry, artificial intelligence, structural biology, and proteomics, Monte Rosa is advancing a pipeline of therapeutic candidates primarily for cancer and other serious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-12 | English | |
| 10-Q | 2025-11-06 | English | |
| 8-K | 2025-11-06 | English | |
| Major Shareholding Notification 2025 | 2025-10-31 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13312702 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13312701 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13312703 | Major Shareholding Notification 2025 | 2025-11-12 | English | ||
| 13312704 | 10-Q | 2025-11-06 | English | ||
| 13312705 | 8-K | 2025-11-06 | English | ||
| 13312706 | Major Shareholding Notification 2025 | 2025-10-31 | English | ||
| 13312707 | Major Shareholding Notification 2025 | 2025-10-17 | English | ||
| 13312709 | Major Shareholding Notification 2025 | 2025-10-03 | English | ||
| 13312710 | 8-K | 2025-09-15 | English | ||
| 13312711 | Regulatory Filings 2025 | 2025-08-21 | English | ||
| 13312712 | Major Shareholding Notification 2025 | 2025-08-14 | English | ||
| 13312714 | 10-Q | 2025-08-07 | English | ||
| 13312713 | 8-K | 2025-08-07 | English | ||
| 13312715 | Regulatory Filings 2025 | 2025-07-22 | English | ||
| 13312717 | Regulatory Filings 2025 | 2025-07-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Monte Rosa Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32920/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32920 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32920 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32920 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32920}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Monte Rosa Therapeutics, Inc. (id: 32920)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.